286 related articles for article (PubMed ID: 22486168)
1. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.
El-Hussuna A; Andersen J; Bisgaard T; Jess P; Henriksen M; Oehlenschlager J; Thorlacius-Ussing O; Olaison G
Scand J Gastroenterol; 2012 Jun; 47(6):662-8. PubMed ID: 22486168
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
Syed A; Cross RK; Flasar MH
Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
[TBL] [Abstract][Full Text] [Related]
3. The impact of preoperative biologic therapy on anastomotic complications after surgery for Crohn's disease.
Yamamoto T; Shiraki M
Scand J Gastroenterol; 2012 Dec; 47(12):1521-2. PubMed ID: 22809295
[No Abstract] [Full Text] [Related]
4. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
[TBL] [Abstract][Full Text] [Related]
6. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD
Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.
Bafford AC; Powers S; Ha C; Kruse D; Gorfine SR; Chessin DB; Bauer JJ
J Clin Gastroenterol; 2013 Jul; 47(6):491-5. PubMed ID: 23090048
[TBL] [Abstract][Full Text] [Related]
8. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
Shental O; Tulchinsky H; Greenberg R; Klausner JM; Avital S
Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease.
Kanazawa A; Yamana T; Okamoto K; Sahara R
Dis Colon Rectum; 2012 Sep; 55(9):957-62. PubMed ID: 22874602
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?
Canedo J; Lee SH; Pinto R; Murad-Regadas S; Rosen L; Wexner SD
Colorectal Dis; 2011 Nov; 13(11):1294-8. PubMed ID: 20969715
[TBL] [Abstract][Full Text] [Related]
11. Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.
Klein M
Dan Med J; 2012 Mar; 59(3):B4420. PubMed ID: 22381097
[TBL] [Abstract][Full Text] [Related]
12. A Practical Predictive Index for Intra-abdominal Septic Complications After Primary Anastomosis for Crohn's Disease: Change in C-Reactive Protein Level Before Surgery.
Zuo L; Li Y; Wang H; Zhu W; Zhang W; Gong J; Li N; Li J
Dis Colon Rectum; 2015 Aug; 58(8):775-81. PubMed ID: 26163957
[TBL] [Abstract][Full Text] [Related]
13. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn's disease surgery.
Resegotti A; Astegiano M; Farina EC; Ciccone G; Avagnina G; Giustetto A; Campra D; Fronda GR
Dis Colon Rectum; 2005 Mar; 48(3):464-8. PubMed ID: 15719193
[TBL] [Abstract][Full Text] [Related]
14. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery.
Tzivanakis A; Singh JC; Guy RJ; Travis SP; Mortensen NJ; George BD
Dis Colon Rectum; 2012 May; 55(5):558-62. PubMed ID: 22513434
[TBL] [Abstract][Full Text] [Related]
15. Short-term complications of wide-lumen stapled anastomosis after ileocolic resection for Crohn's disease: who is at risk?
Riss S; Bittermann C; Zandl S; Kristo I; Stift A; Papay P; Vogelsang H; Mittlböck M; Herbst F
Colorectal Dis; 2010 Oct; 12(10 Online):e298-303. PubMed ID: 20041915
[TBL] [Abstract][Full Text] [Related]
16. [Inflammatory bowel diseases--new therapeutic options].
Herrlinger K; Stange EF
Med Klin (Munich); 2008 Feb; 103(2):90-101; quiz 102-3. PubMed ID: 18270665
[No Abstract] [Full Text] [Related]
17. Sequential therapies for Crohn's disease: optimizing conventional and biologic strategies.
Desilva S; Kaplan G; Panaccione R
Rev Gastroenterol Disord; 2008; 8(2):109-16. PubMed ID: 18641593
[TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy with certolizumab pegol for Crohn's disease.
Schreiber S; Khaliq-Kareemi M; Lawrance IC; Thomsen OØ; Hanauer SB; McColm J; Bloomfield R; Sandborn WJ;
N Engl J Med; 2007 Jul; 357(3):239-50. PubMed ID: 17634459
[TBL] [Abstract][Full Text] [Related]
19. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
August DA; Serrano D; Poplin E
J Surg Oncol; 2008 Feb; 97(2):180-5. PubMed ID: 18095268
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
